On March 18, the Social Security Administration published a ruling in the Federal Register for the evaluation of interstitial cystitis (IC) in adults and children. The new ruling, SSR 15-1p, rescinds and replaces prior SSR 02-2p for establishing IC as a medically determinable impairment (MDI) and determining disability. It takes into consideration descriptions of IC recently developed by the American Urological Association and the National Institute of Diabetes and Digestive and Kidney Diseases. In the new SSR, the following evidence can establish the MDI of IC: a diagnosis of IC by an acceptable medical source who reviewed the claimant’s medical history and conducted a clinical examination; IC symptoms, as indicated in the AUA and NIDDK descriptions; and medical signs or laboratory findings.
The new SSR also provides guidance in the following areas of adjudication: obtaining medical and other evidence; arranging consultative examinations; resolving inconsistencies in the evidence; evaluating claimants’ statements about symptoms and functional limitations; and using the five-step sequential evaluation process for determining disability